Tags (2) : older adults
Clover Biopharma Advances Phase 2 Trial for RSV Combination Vaccines
01/12/2026 | Companies
Australia clinical trial,
biotechnology company,
clinical research,
Clover Biopharmaceuticals,
combination vaccines,
global health,
hMPV vaccine,
immunogenicity,
infectious diseases,
older adults,
Phase 2 clinical trial,
PIV3 vaccine,
prefusion-stabilized F protein,
protein-based vaccines,
respiratory vaccines,
RSV vaccine,
Trimer-Tag technology,
vaccine development,
vaccine safety
Most Popular Now
Environment News
Compliance
Want to write a piece for Daily CSR? Please contact us by email at editor[@]dailycsr.com


Companies